GFN News

#GFN25 Science Discussion #13 | HTP Use Patterns and verified smoking status in HTP customers by GFN.TV

Behavioral science consultant Arielle Selya joins GFN News to discuss her new YouTube channel and why she’s breaking down tobacco harm reduction research. From misperceptions about vaping to the gateway hypothesis, she explains what the science actually shows—and how studies are often misrepresented.

A massive opportunity to reduce smoking-related death is being squandered. In this episode of GFN Interviews, cardiometabolic physician Dr. Rohan Sequeira examines how public health distorts the public’s understanding of nicotine and risk. With South Asia bearing an enormous tobacco burden, he explains why traditional cessation approaches are failing, why safer nicotine products matter, and how mi...

In our next Science Lab session Dr Marewa Glover presents the key findings of the Voices of the 5% Study, a 4-year longitudinal qualitative study of New Zealand adults who used vapes but had no intention of quitting smoking.

In Part 2, Bengt Wiberg explains why EU nicotine policy should be science-based, not political. Drawing on Sweden’s success, he challenges cancer myths, youth claims, and makes the case for smart regulation to reduce smoking and save lives.

EU nicotine policy is under fire after claims that smoke-free nicotine products are as harmful as cigarettes. In GFN News, Joanna Junak interviews Bengt Wiberg of Stingfree AB on why experts dispute these statements, what science says about nicotine pouches, snus, and vaping, and how the debate could impact tobacco harm reduction and future EU regulation.

2026 could be a turning point for nicotine policy in Africa. In this episode of GFN News, Joanna Junak speaks with Joseph Magero, consumer advocate and Chairman of the Campaign for Safer Alternatives, about the challenges and opportunities for harm reduction, the impact of restrictive policies, and how countries like South Africa, Kenya, and Nigeria are shaping the future of safer nicotine product...

#GFN25 Science Discussion #11 | Research gaps, priorities and advocate readiness for THR in LMICs by GFN.TV

Public health often warns about tobacco industry interference—but what happens when tobacco control itself is captured by benevolent donors and non-profit organizations? In this GFN interview, economist Roger Bate explains why the World Health Organization’s Framework Convention on Tobacco Control is uniquely vulnerable to outside influence, how Bloomberg-funded NGOs shape policy agendas upstream,...

Giusy Rita Maria La Rosa's systematic review and network meta-analysis of 36 randomised contol trials examines the oral health effects of non-combustible nicotine products. Dr Riccardo Polosa takes questions from GFN25 attendee's.

A new European Heart Journal report has reignited the debate over nicotine, heart health, and harm reduction. In this GFN News interview, Will Godfrey of Filter examines the claims that all forms of nicotine pose equal cardiovascular risk and the strong backlash from independent experts. The discussion explores criticisms of the report’s scientific approach, evidence from population studies, and c...

In another Science Lab session Dr Roberto Sussman provides a critiques of e-cigarette aerosol studies and discusses the methodological problems that persist with emission studies, such as overheating coils to produce aldehydes and manufacturing harms.

Six months after the UK’s disposable vape ban, questions remain over its real-world impact. Industry commentator Martin Cullip discusses weak enforcement funding, the rise of illegal sales, growing environmental awareness, and concerns that the ban could undermine smoking cessation and push some users back to cigarettes.

Part two of the interview will air on Wednesday, January 14th! Join Joanna Junak and Martin Cullip as they break down the UK Tobacco and Vapes Bill, expected to become law in 2026. We explore the generational smoking ban, vaping and nicotine regulations, and potential impacts on adult users. Learn why nicotine pouches, flavor restrictions, and ministerial powers are sparking debate, and how consum...

America’s tobacco policy has turned self-destructive. Safer nicotine products are demonized and restricted while combustible cigarettes remain widely available. In this GFN interview, Michelle Minton of the Reason Foundation explains how fear, ideology, and institutional incentives replaced evidence in U.S. tobacco control—pushing consumers back toward smoking and undermining one of the greatest p...

Looking ahead to 2026, Nick "GrimmGreen" Green and Professor Tikki Pang share their hopes and predictions for tobacco harm reduction worldwide. From clear, science-based messaging about vaping and nicotine pouches to the dangers of prohibition and illicit products, they discuss what changes are needed - and what might realistically happen. Discover their insights on creating safer alternatives and...

In 2025, the world saw both progress and setbacks in tobacco control. Sweden became officially smoke-free through effective risk-reduction policies, while Mexico implemented strict bans on vaping and harm-reduction tools, fueling black markets and uncertainty. Meanwhile, countries like Chile are leading the way with regulations that recognize safer alternatives.

In this video, experts Carmen Escrig and Ian Fearon discuss the global shift in tobacco harm reduction and the fight against prohibitionist policies. From Spain to the UK, brave policymakers are challenging outdated laws and advocating for science-based regulations that save lives. As we look toward 2026, there is hope for a world where adult smokers have safer alternatives and governments priorit...

A powerful closing address from David Sweanor, a pioneering public health lawyer, delivered at the 12th Global Forum on Nicotine (GFN). In this concluding keynote, he reflects on the diverse perspectives within the tobacco harm reduction community, the challenges posed by opposition to new technologies, and the global momentum toward reduced-risk nicotine products. David highlights historical patt...

Global Forum on Nicotine 2025 Closing remarks by David Sweanor by GFN.TV

As policymakers look ahead to 2026, experts from Ireland and the United States share one clear hope for tobacco harm reduction: protect vape flavors. In this discussion, Dr. Garrett McGovern and AG Tom Miller explains why flavors are critical to keeping adults away from smoking - and why banning them could backfire, leading to higher cigarette use, including among youth. He argues that enforcing a...

As 2026 approaches, policymakers face a critical choice: continue repeating failed tobacco strategies or finally listen to science, consumers, and real-world evidence. In this discussion, Fiona Patten and Fernando Bueno examine why Australia’s tobacco tax revenue has collapsed, how harm reduction products like vaping are being wrongly regulated, and what countries like Sweden and New Zealand have...

Discover how oral nicotine pouches could represent the next frontier in tobacco harm reduction, with a deep dive into their chemistry, toxicology, and real-world use data compared with cigarettes and traditional snus. In this Science Lab session, Chris presents new evidence on toxicant reduction, biomarkers of exposure and potential harm, pharmacokinetics, and user behavior across different market...

Join us for a fast-moving roundup of the most significant tobacco harm reduction developments of 2025. From FCTC COP11 controversies and global bans to new scientific insights, advocacy efforts, and major policy shifts, Will Godfrey breaks down the year’s biggest stories. Discover where progress is being made, where setbacks continue, and how real-world consumers are shaping the future of safer ni...

Join GFN.TV and Michael Landl from the World Vapors Alliance as they break down COP11’s impact on tobacco harm reduction. Discover how countries challenged WHO recommendations, delayed restrictive measures, and pushed for evidence-based policies. Learn what this means for EU regulations, harm reduction strategies, and the global fight for safer nicotine alternatives.